US12421254B2ActiveUtilityA1
KRAS modulators and uses thereof
Est. expiryMar 15, 2043(~16.7 yrs left)· nominal 20-yr term from priority
C07D 495/10A61P 35/00A61K 31/551C07D 495/20C07D 471/08A61K 31/553C07F 9/6561C07D 487/08A61K 31/675A61K 31/55C07D 519/00C07D 487/04A61K 31/554A61K 31/5377A61K 31/53
74
PatentIndex Score
0
Cited by
162
References
17
Claims
Abstract
Provided herein are KRAS modulating compounds, such as compounds of Formula (I), (I-A), (I-B), (I-C), (I-C*), (I-D), (I-E), (I-F), (I-G), (I-H), (I-I), (I-J), or pharmaceutically acceptable salts, solvates, stereoisomers, atom labelled, or tautomers of any one thereof. The compounds provided herein are useful for modulating KRAS G12D and/or other G12 mutants.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A compound selected from
or a pharmaceutically acceptable salt of any one thereof.
2. A compound selected from
or a pharmaceutically acceptable salt of any one thereof.
3. A pharmaceutical composition comprising the compound or salt of claim 1 and a pharmaceutically acceptable excipient.
4. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
5. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
6. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
7. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
8. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
9. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
10. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
11. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
12. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
13. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
14. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
15. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
16. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
17. The compound or salt of claim 1 , wherein the compound is
or a pharmaceutically acceptable salt thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.